Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

The legal regulation of drugs and role of government: Perspectives from people who use drugs

This study aimed to examine the views of people who use drugs and who are deeply impacted by drug policies to understand the perceived impacts and role of government under a legalized-regulated market
Original research | 2020
Policy/Regulatory, Decriminalization/legalization, Equity, About PWUD, Peer/PWLLE program involvement

Treatment-seeking behaviour among people with opioid use disorder in the high-income countries: A systematic review and meta-analysis

To determine treatment seeking behaviour in those with opioid use disorder (OUD) in the high-income countries.
Lit review | 2021
About PWUD, Barriers and enablers

Youth Cannabis use and Legalization in Canada – Reconsidering the Fears, Myths and Facts Three Years In

We reconsider the arguments made about the potential consequences of legalization for youth, centered on three key concerns: that prevalence would significantly increase, that there would be greater i
Original research | 2021
Evidence base, Policy/Regulatory, Decriminalization/legalization, Equity, Youth

‘Not at all what I had expected’: Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study

Extended-release naltrexone (XR-NTX), an opioid antagonist, has demonstrated equal treatment outcomes, in terms of safety, opioid use, and retention, to the recommended OMT medication buprenorphine.
Original research | 2021
About PWUD, Substitution/OAT

‘Peer’ work as precarious: A qualitative study of work conditions and experiences of people who use drugs engaged in harm reduction work

We examine the qualitative accounts of people who use drugs engaged in ‘peer’ work in harm reduction settings across British Columbia.
Original research | 2020
Equity, About PWUD, Workplace, Peer/PWLLE program involvement, Social benefits

A chance to do it better: Methadone maintenance treatment in the age of Covid-19

Commentary | 2020
Policy/Regulatory, About prescribers, About PWUD, Barriers and enablers, Substitution/OAT, Stigma, Carries/take-home doses

A public health based vision for the management and regulation of opioids

Three models to support jurisdiction specific discussions around the world.
Commentary | 2021
Policy/Regulatory

An introductory guide for assessing and understanding common wounds with people who inject drugs

Guide or handbook | 2020
Clinical guidance, Harm reduction, Illegal drugs, Injecting drugs

Comparing characteristics and outcomes of different opioid agonist treatment modalities among opioid-dependent federal men correctional populations in Canada

Examine key characteristics and outcomes of men in Canadian federal correctional institutions across treatment modalities.
Original research | 2022
Outcomes, Legal system/law enforcement

Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market

This qualitative study was conducted to better understand how people who inject drugs (PWID) came to recognize fentanyl as a growing adulterant of heroin and the subsequent sensory discernment strateg
Original research | 2022
Harm reduction, About PWUD, Illegal drugs, Stimulants

Detecting risk level in individuals misusing fentanyl utilizing posts from an online community on Reddit

Because those who misuse fentanyl are often a hidden and high risk group, innovative methods for identifying individuals at risk for fentanyl misuse are needed.
Original research | 2021
Harm reduction, Illegal drugs, Digital health

Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial

To test the efficacy of 3 interventions for opioid dependence: (1) screening and referral to treatment (referral); (2) screening, brief intervention, and facilitated referral to community-based treatm
Original research | 2015
About prescribers, Outcomes, Illegal drugs, Substitution/OAT, Transitions in care/treatment, Hospitals

Going Nowhere: Ambivalence about Drug Treatment during an Overdose Public Health Emergency in Vancouver

The declaration of an overdose public health emergency in Vancouver has generated an “affective churn” of intervention across youth‐focused drug treatment settings, including the expanded provision of
Original research | 2021
Wrap-around services, About PWUD, Social services, Housing, Illegal drugs, Youth, Indigenous, Substitution/OAT

Perceived healthcare stigma among patients in opioid substitution treatment: a qualitative study

To explore OST patients’ past and present experiences of substance use stigma in healthcare settings
Original research | 2021
Barriers and enablers, Stigma

Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection

While opioid agonist therapy (OAT) reduces the risk of hepatitis C virus (HCV) acquisition among people who inject drugs (PWID), protective effects may be attenuated in females.
Original research | 2020
Harm reduction, Advocacy, Outcomes, Sex/Gender

Stimulant safe supply: a potential opportunity to respond to the overdose epidemic

Commentary | 2020
Safer supply, Equity, Barriers and enablers, Poverty, Stimulants, Peer/PWLLE program involvement

Supervised consumption services for acute care hospital patients

Commentary | 2020
Harm reduction, Policy/Regulatory, About prescribers, Illegal drugs, Stigma, SCS/OPS, Hospitals

The DULF Compassion Club project

Archived webinar | 2021
Harm reduction, Policy/Regulatory, Safer supply, Decriminalization/legalization, Advocacy, About PWUD, Illegal drugs

The essential role of pharmacists in the opioid crisis

Support pharmacists in naloxone provision, overdose prevention, etc.

Commentary | 2017
Overdose, Hesitancy of prescribers , About pharmacists

The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime

Aimed to model the effect of Australia's first Medically Supervised Injecting Centre (MSIC) on acquisitive crime and loitering by drug users and dealers
Original research | 2009
Crime, Illegal drugs, SCS/OPS

Refine Your Search

Keywords
Format
Region